Molecular Biology Assay Service
Inquiry
Cancer is fundamentally a disease of dysregulated gene expression, driven by mutations, epigenetic alterations, and aberrant signaling pathways. Traditional endpoint measurements, such as single mRNA expression snapshots or end-point PCR analysis, often provide static views that miss critical signals of drug response, resistance evolution, or early metastatic dissemination. Alfa Cytology offers comprehensive molecular biology assay services designed to precisely dissect, quantify, and track molecular events in cancer, delivering dynamic, multidimensional data to accelerate go/no-go decisions and deepen mechanistic insights.
Introduction to Molecular Biology Assay
Understanding the molecular events underlying cancer initiation and progression is a prerequisite for identifying novel therapeutic targets, predicting drug responses, and evaluating treatment efficacy. Molecular biology provides systematic tools to decode these complex processes at the genomic and epigenomic levels, driving a paradigm shift from descriptive observation to mechanistic understanding. At its core, the discipline focuses on the multi-layered, multi-dimensional characterization of the molecular landscape that governs tumorigenesis, malignant progression, and therapeutic response, thereby establishing a robust theoretical foundation for precision oncology.
Genomic Characterization
Identifies driver mutations, copy number variations, and structural rearrangements to assess TMB and predict targeted therapy responses, enabling early patient stratification and biomarker discovery.
Epigenetic Analysis
Reveals DNA methylation, histone modifications, and chromatin accessibility changes that silence tumor suppressors or activate oncogenes, supporting epigenetic-targeted and combination therapies.
Transcriptional Profiling
Monitors mRNA, non-coding RNA, and splicing variants post-intervention via qPCR, providing real-time insights into MOA, pharmacodynamics, and resistance pathways.
Fig. 1 Typical workflow for ddPCR in cancer liquid biopsies. (Budhbaware T, et al.; 2024)
Our Services
Alfa Cytology offers a comprehensive suite of molecular biology assay services designed to support cancer research and preclinical drug development, from target discovery and biomarker identification to mechanistic validation and combination strategy optimization.
Our molecular biology assay platform integrates quantitative PCR, methylation analysis, nucleic acid quantification, vector construction, and advanced detection technologies to deliver high-quality molecular data. Whether you are validating novel drug targets, characterizing tumor models, or investigating resistance mechanisms, our services provide the precision and reproducibility needed for confident decision-making.
Test Types
Real-Time Quantitative PCR (qPCR)
qPCR is the gold standard for gene expression analysis, enabling precise quantification of mRNA transcripts. Our services support target validation, biomarker quantification, pharmacodynamic monitoring, and pathway assessment, with optimized assays and rigorous QC for:
- Gene expression profiling in tissues and cell lines
- Pharmacodynamic biomarker quantification
- Validation of transcriptomic data
- Monitoring response marker dynamics
miRNA Detection and Expression Profiling
miRNAs are key regulators in cancer progression and drug resistance, serving as promising biomarkers and therapeutic targets. Our services offer sensitive and specific quantification of mature miRNAs for:
- miRNA expression profiling in tumors and liquid biopsies
- Biomarker identification and validation
- miRNA regulatory network analysis
- Pharmacodynamic monitoring of miRNA-targeted therapies
DNA Methylation Analysis
Aberrant DNA methylation is a hallmark of cancer. Our services provide gene-specific and genome-wide methylation characterization to support:
- Epigenetic target identification
- Biomarker discovery
- Mechanistic studies of epigenetic therapies
- Dynamic methylation profiling post-drug intervention
Nucleic Acid Quantification and Quality Assessment
Precise nucleic acid quantification and quality assessment are essential for downstream applications. We use fluorometric and capillary electrophoresis technologies to deliver accurate DNA/RNA quantification and integrity evaluation for:
- DNA preparation for sequencing and cloning
- RNA preparation for expression analysis
- Quality control for molecular applications
Plasmid Vector Construction
Custom plasmid vectors enable gene manipulation and functional studies across various cell systems. We provide sequence-verified construction services for:
- Overexpression and knockdown constructs
- Reporter vectors for pathway and promoter analysis
- CRISPR/Cas9 guide RNA vectors
- Viral backbones for delivery and stable expression
Other Biological Technologies
Our platform integrates advanced technologies to address specialized research questions, supporting:
- Custom assay development for novel biomarkers
- Advanced nucleic acid analysis for translational research
- Tailored molecular solutions for unique research needs
- Mechanistic studies for combination therapy strategies
Supported Therapeutic Modalities
Our molecular biology assay services broadly support diverse cancer therapy R&D, providing high-quality molecular data for target validation, biomarker discovery, pharmacodynamic monitoring, and mechanistic studies to inform your critical R&D decisions.
Available Model Systems
Our molecular biology assay services are applicable to a wide range of cancer research models, providing reliable data support for target validation, pharmacodynamic evaluation, and mechanistic studies across different stages of drug development.
Applications of Our Molecular Biology Service
Our molecular biology assay platform is broadly applicable across the following research areas, delivering precise data to support your target discovery, mechanistic validation, and preclinical evaluation.
Supports the entire target discovery pipeline,from candidate identification to functional characterization and mechanistic validation, by integrating gene expression analysis, epigenetic profiling, and functional studies to link potential targets to disease biology and therapeutic sensitivity.
Mechanism-of-Action Studies
Provides tools to characterize compound mechanisms at the molecular level, including gene expression regulation, epigenetic modifications, and signaling pathway activities, to directly support IND-enabling studies and regulatory submissions.
Enables precise quantification of pharmacodynamic markers to support dose selection, regimen optimization, and go/no-go decisions. Gene expression, methylation, and miRNA markers serve as sensitive readouts of target engagement and pathway modulation, delivering critical data for translational research and clinical trial design.
Model Characterization and Molecular Profiling
Supports molecular characterization of cell lines, organoids, and PDX models through multidimensional profiling, including gene expression, methylation, and miRNA signatures, to enable precise matching of preclinical models to specific disease subtypes.
Alfa Cytology offers flexible molecular biology assay services covering gene expression analysis, miRNA profiling, DNA methylation detection, nucleic acid quantification, and plasmid vector construction. Our solutions support small molecule drugs, therapeutic antibodies, cell and gene therapies, cancer vaccines, and oncolytic viral therapies, with customizable options from single assays to integrated R&D packages. Please don't hesitate to contact us to learn how our molecular biology assay services can accelerate your oncology drug discovery and development.
Reference
- Budhbaware T, et al. Molecular methods in cancer diagnostics: a short review. Ann Med. 2024;56(1):2353893.
For research use only.
Related Services
